DLA Piper LLP (US)

Corporate; Mergers and Acquisitions; Emerging Growth and Venture Capital; Capital Markets; Intellectual Property and Technology; Regulatory and Government Affairs; Life Sciences; Healthcare

Partner, Regional Office Head for Baltimore Corporate & Securities Group

Howard Schwartz structures and negotiates mergers and acquisitions, complex collaborations, joint ventures, and financings for clients ranging from multinational bio-pharmaceutical and device companies to start-up biotechs. Additionally, he advises boards of directors and significant shareholders on disclosure issues, corporate communications policies, and fiduciary duty matters. His clients and deal experience extend throughout the United States, Europe and Asia as well to emerging markets and include all segments of the industry – pharma, biotech, medtech, diagnostics, animal health, vaccines and health services.

In addition, Howard regularly represents life sciences companies in their operational matters, such as global supply, distribution, clinical trials, manufacturing, and research and license arrangements between industry and academic institutions.

English, Russian

J.D., University of Virginia; B.A., Brown University